调研行业：商业百货 参与调研的机构：线上参与湖北辖区上市公司2025年投资者集体 接待日活动暨2024年度业绩说明会等 / 机构调研pro小程序 DJvanbao.com 洞见研报 出品 : 居然之家分析师会议 调研日期：2025年06月12日 机构调研pro小程序致力于为金融证券投资者提供最新最全的调研会议纪要。 来机构调研pro小程序，了解最新的：行业投资风向、热门公司关注、权威机构分析... 权威完善的信息持续更新! 更多精彩的机构调报告请移步机构调研pro小程序~ 一解投资机构行业关注度。 频判市场 | Gallia | | | --- | --- | | 11 2 12 200 2 110 | | | 1:给我们 = 影片面临官 = | | | 阿里巴巴佩尼 | | | 钢铁机之题。 8 | 图纸制图: 23 | | 20GB Millio Aller 19 | | | 海双集团 | | | 1 1 80.0 0 | 总机构建 23 | | LOGA: REGH, KETA: 1986 | | | 小麦具日 | | | 的研究次数:8 | 上机构馆:23 | | 定年代的:用者点击:我要的中:主要原 ...

居然智家新零售集团股份有限公司 证券代码：000785 证券简称：居然智家 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | 投资者关 | ☐媒体采访 业绩说明会 | | 系活动类 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | 别 | ☐其他 | | 参与单位名 | 线上参与湖北辖区上市公司2025年投资者集体接待日活动暨2024年度业绩说明会 | | 称 | | | 时间 | 2025年06月12日 15:50-16:50 | | 地点 | 全景网（https://rs.p5w.net/html/147973.shtml）网络平台 | | | 董事兼执行总裁（代行董事长、CEO职责）王宁先生 | | 上市公司 | | | 接待人员 | 副总裁朱蝉飞女士 | | 姓名 | 董事会秘书王建亮先生 | | | 1、公司年初发布的2025年五大计划，除了参加GTC大会，其他计划进展如何？为什 | | | 么没有进展公告？智能家居研究院和北京新能源汽车交付中心现进展如何？ | | | 回复：2025年经济政策的着力点转向扩内需、促消费，也是国补大年，公司依 | | 投资者关 ...

武商集团股份有限公司投资者关系活动记录表 | | A 级、武商集团人工智能应用创新创业大赛十佳团队，2024 年 | | --- | --- | | | "我为湖北好货代言"直播电商大赛优秀奖等。 | | | 四、武商梦时代和南昌武商 MALL 项目是否已经开始扭亏为 | | | 盈？两个项目在品牌引进方面有哪些亮点？ | | | 答：目前，武商梦时代经营势头良好，南昌武商 MALL 于 2023 | | | 年 4 月开业，目前，仍处于提升经营质效阶段。武商梦时代在 | | | 品牌引进上，贴合新消费趋势，定位"以家庭欢聚为主题的社 | | | 交平台"，倡导城市中心"微度假"生活方式。2024 年"首 | | | 店首展首发"集群高频更新，如公司首个黄金珠宝自运营项目 | | | 周大福时尚店；点都德华中首店、蔡澜点心华中首店等特色餐 | | | 饮；运动品牌 Salomon、UAOUTDOOR 华中首店，安踏冠军湖北 | | | 首店；国际彩妆品牌华伦天奴湖北首家精品店，Crocs 卡骆驰 | | | 全球首家旗舰店、超级猩猩武汉首家综合训练店等相继登场， | | | 持续扩充国内外头部品牌矩阵，不断给 ...

6月12日，东吴人寿 "乐享健康，智迎未来" 客户服务月在苏州高新区狮山国际会议中心正式开幕。此次活动积以金融提振消费专项行动为指引，深入贯彻落 实市委市政府"促消费、惠民生"工作部署，通过产品创新、服务升级与科技赋能，为广大市民构建"全域行进式"金融保险服务新体系。 点击输入图片描述（最多30字） 开幕式现场，东吴人寿围绕产品创新、服务体系和科技赋能三个维度，推出三大核心亮点，充分体现"以客户为中心"的发展理念。 产品创新方面，针对不同客群需求推出两款专属产品。面向苏州高层次人才及创新创业企业家推出"臻康护"，全面覆盖住院、门急诊及特定药械责任，为优 化城市人才服务生态，激发城市创新创业活力提供坚实健康保障；响应个人养老金政策号召推出"东吴惠享恒悦两全保险"，统筹保障与养老资金规划需求， 积极构建养老新生态。 点击输入图片描述（最多30字） 服务体系方面，"153"全方位服务体系正式发布，"1个货架"整合数百项服务资源，"吴悠医、吴悠享、吴悠学、吴悠行、吴悠福"5大系列31项服务实现全生 活场景覆盖，"产品+服务、客户俱乐部、营销服务"3类模式精准触达客户群体，实现"以客户为中心，全维守护"的服务承诺。 点 ...

Core Insights - The 10th Smart Pharmaceutical Academic Industry Conference was held in Tianjin, showcasing advancements in traditional Chinese medicine and smart manufacturing [1][3] - Tianshili Pharmaceutical Group played a significant role in the conference, presenting its strategic layout and technological breakthroughs in smart manufacturing [3][10] - The conference emphasized the importance of digital transformation in the pharmaceutical industry, with Tianshili leading initiatives to establish industry standards [3][10] Group 1: Conference Highlights - The conference gathered over 300 industry elites and top experts, including Academician Zhang Boli, to discuss the future of smart pharmaceuticals [1] - Tianshili's Chairman Zhou Hui and other executives presented reports on the company's advancements in digital quality systems and smart manufacturing technologies [3][5] - The event featured the launch of the "Pharmaceutical Industry Digital Action Tianjin Initiative," highlighting Tianshili's leadership in industry transformation [3][10] Group 2: Technological Innovations - Tianshili's digital quality system integrates blockchain traceability, AI process optimization, and smart equipment control, enhancing product quality consistency to international standards [5][12] - The company developed a fifth-generation high-speed jet granulator, addressing production challenges and significantly improving efficiency [7][8] - Tianshili's smart production line automates the entire process from raw material input to finished product packaging, showcasing its commitment to technological advancement [8][12] Group 3: Research and Development - Tianshili has established a comprehensive R&D model that integrates modern Chinese medicine, biopharmaceuticals, and precision medicine, leading to the launch of new products [12] - The company has completed three new drug registration applications and seven clinical research applications in the past year, with a pipeline of 98 products, including 33 innovative drugs [10][12] - Tianshili's commitment to digital transformation and R&D innovation positions it as a leader in modernizing the traditional Chinese medicine industry [12][13] Group 4: Future Outlook - The release of the Tianjin Initiative marks a new phase of collaborative innovation in the pharmaceutical industry's digital transformation [13] - Tianshili aims to empower the health of China through its "Digital Chinese Medicine + Innovative Chinese Medicine" strategy, emphasizing the necessity of digital transformation for the industry [13] - The company is poised to continue leading the modernization of traditional Chinese medicine through technological advancements and patient-centered approaches [13]

上海印发《深化新时代中小学体育工作高质量发展的若干措施》，其中指出挖掘校内场地资源。新建学 校要提高体育场地建设标准。已建成学校灵活运用"上天入地""立体扩容"等办法，加大场地建设力度。 完善室内健身设施，鼓励建设运动休整室或提供相应的功能空间。开发室内场地潜力，做好特殊天气等 情况下的运动安排。加强"一场多能"，充分利用跨学科学习空间、走廊、楼道等学生身边的"角角落 落"，划定小型运动场域，配置小型健身运动设备，打造"微操场""微球场"。鼓励引入数智化设备，打 造新运动场景，吸引学生主动锻炼。(上海市人民政府) ...

Core Insights - Huayang Group is enhancing its supply chain management through the development of a transparent and efficient e-commerce procurement platform [1][3] Group Development Journey - In 2018, Huayang Group partnered with JD.com to create the "JD Smart Procurement" platform, becoming the first in the coal industry to implement e-commerce procurement [2] - In the first five months of the platform's launch, Huayang Group procured 2,846 types of goods totaling 7.5 million yuan, achieving a price reduction of 4.1% compared to JD.com [2] - By 2020, Huayang Group expanded its e-commerce capabilities by collaborating with Nasda to create a one-stop online procurement service platform, inviting multiple e-commerce companies to join [2] - In early 2023, Huayang Group initiated the "Huayang E-commerce Platform 3.0" project in partnership with Alibaba Cloud, aiming to build a smart supply chain digital platform [2] - The new platform is set to officially launch in November 2023 and will be fully promoted by March 2024 [2] New Operational Model - The Huayang e-commerce platform features modules for operations, marketplace, suppliers, and data integration, allowing for comprehensive management of the procurement process [4] - The platform enables self-management of suppliers, products, orders, after-sales, reconciliation, and invoicing, enhancing control over the procurement process [4] - New modules for product management and online acceptance improve management precision and facilitate supplier and product scoring [4] Procurement Experience - The Huayang e-commerce platform 3.0 has onboarded 214 purchasing units and 74 suppliers, with 160,000 products listed and a total transaction amount of 370 million yuan [5] - The procurement process has become significantly more efficient, with order processing from demand submission to delivery acceptance now completed within 10 days [5] - The platform has also reduced procurement costs, with a savings rate of 9.13% achieved through centralized management and enhanced bargaining power [5] Future Directions - Huayang Group plans to focus on data-driven, AI-enabled, and secure management of its e-commerce platform, aiming for improved product aggregation, price monitoring, and lifecycle management of suppliers [6]

Core Viewpoint - The establishment of a digital comprehensive management platform for the entire industrial chain of medicinal herbs, particularly for the cultivation and processing of Mai Dong (Ophiopogon japonicus), is being promoted in Sichuan Province, enhancing quality control and ensuring farmers' benefits through standardized practices and innovative financial services [5][11]. Group 1: Digital Management and Quality Control - The construction of a digital comprehensive management platform integrates planting, processing, storage, sales, quality inspection, and finance, utilizing modern digital technologies for traceability [5][11]. - The introduction of a digital system allows for precise monitoring of the entire cultivation and processing process, ensuring compliance with standardized practices [7]. - Each batch of Mai Dong is assigned a unique QR code after passing strict quality checks, providing detailed information about its origin, composition, and environmental conditions [7][8]. Group 2: Storage and Supply Chain Management - The physical storage facility can hold 6,500 tons of Mai Dong, ensuring compliance with pharmacopoeia standards for up to three years and optimizing storage space to prevent damage [8]. - The storage facility plays a crucial role in market stabilization by maintaining a buffer stock of 1,000 tons of Mai Dong to mitigate price fluctuations and supply shortages [8]. Group 3: Farmer Support and Financial Services - The order production model between the storage facility and farmers guarantees reasonable returns regardless of market conditions, enhancing farmers' confidence [9]. - The development of a supply chain financial cloud platform provides various financial services, including loans for agricultural inputs and insurance products, supporting the entire Mai Dong industry chain [10]. Group 4: Innovation and Industry Development - The introduction of a third-party quality control system and collaboration with research institutions aims to enhance the standardization and quality management of Mai Dong production [10]. - The expansion into derivative products, such as beverages and personal care items, aims to increase the value of the Mai Dong industry and promote integrated development across different sectors [10].

Core Viewpoint - The company emphasizes that chaotic price wars are detrimental to the sustainable development of the medical industry and will harm patient rights [1][2]. Group 1: Company Insights - Aier Eye Hospital has seen a steady recovery in the average price of refractive surgeries since last year, indicating a gradual industry clearing where demand is shifting towards reputable hospitals [1]. - The company plans to launch upgraded surgical techniques in 2024, including All-Laser LASIK and ICLV5 lenses, to meet diverse patient needs [1]. - Aier Eye Hospital's overseas business revenue is projected to account for approximately 12.5% in 2024, reflecting a 1% increase from the previous year, with plans for further expansion in Europe and Southeast Asia [3]. Group 2: Industry Trends - The aging population is driving demand for age-related eye disease treatments, particularly for presbyopia, which is currently under-recognized in China [2]. - The company anticipates significant growth potential in presbyopia treatment, similar to trends observed in developed countries [2]. - The company's profitability is expected to improve as patient volumes increase, benefiting from economies of scale and reduced sales expense ratios [3].

成立于2020年的天津海河设计集团，是天津国资系统落实天津市部署、整合勘察设计行业资源、建 设"设计之都"的重大举措。目前，天津海河设计集团已成为拥有规划、勘察、测绘、建筑、市政、环 保、园林、水利等勘察设计全产业全链条的大型国有设计企业，人员规模、市场规模、营收能力及资质 水平居全国前列。 未来，天津海河设计集团将加快AI与工程场景深度融合，拓展设计辅助、成果审核等高阶应用，推动 设计范式从"人力密集型"转向"智慧密集型"，项目管理从"碎片化"迈向"全链条协同"，以数智化转型助 推国有企业高质量发展。（经济日报记者 商瑞） 日前，从天津国兴资本运营有限公司获悉，天津海河设计集团有限公司揭牌成立了数字智能研究院，同 时发布了首款自主研发的"天工智景"AI设计平台。数字智能研究院将助力天津海河设计集团实现全产业 链整合创新，在数字化转型与人工智能应用领域实现新突破。 会上，天津海河设计集团发布了"天工智景"AI设计平台1.0版。平台将深度融合DeepSeek等数据大模 型，搭建企业私域知识库，实现高精度推理与轻量化应用。同时，聚焦园林景观方案设计，平台AI园 林助手将实现文字、图片、声音等多模态输入和快速产出， ...